Hinge Health, Inc. (HNGE)
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Sector: Services-Computer Processing & Data Preparation
Industry: Medical - Healthcare Information Services
Hinge Health, Inc.
NYSE:HNGEHealthcare · Medical - Healthcare Information Services
-0.19%$115.76
CLOSED · Nov 6Prev close$115.98-0.19%Close$115.76-0.83%AH close$114.80
AH$114.80-0.83%vs close
Mkt Cap$9.34B
Float54.05M
O/S80.69M
VOL1.54M sh
$ Vol$177.13M
RVOL0.75×
Inst Own75.3%
SI11.7%
Dilution
Financials Summary
Revenue$587.86M
Net Income-$528.26M
Total Assets$744.76M
Free Cash Flow$170.73M
Debt & Equity
Debt 1%
Equity 65%
Preferred 34%
Total Debt$8.04M
Total Equity$378.54M
Preferred Stock$199.87M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in HNGE's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$744.76M
Liabilities$366.23M
Accounts Receivable$66.06M
Accounts Payable$0
Inventory$15.64M
PP&E (Net)$17.35M
Goodwill$64.1M
Intangible Assets$2.51M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Revenue | $587.86M | $390.4M | $292.73M |
| YoY Growth | 50.6% | 33.4% | - |
| Cost of Revenue | $118.56M | $89.81M | $98.55M |
| Gross Profit | $469.3M | $300.59M | $194.18M |
| Gross Margin | 79.8% | 77.0% | 66.3% |
| Research and Development | $368.14M | $100.84M | $110.06M |
| Selling, General, and Administrative | $639.41M | $227.53M | $214.63M |
| Other | $8.12M | $4.13M | $0 |
| Total Operating Expenses | $1.02B | $332.5M | $324.69M |
| Operating Income (EBIT) | -$546.37M | -$31.91M | -$130.51M |
| Operating Margin | -92.9% | -8.2% | -44.6% |
| Interest Expense | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 |
| Other Income (Expense) | $19.11M | $20.65M | $21.97M |
| Income Before Tax (EBT) | -$527.26M | -$11.26M | -$108.55M |
| Income Tax Expense | $998K | $677K | -$405K |
| Net Income | -$528.26M | -$11.93M | -$108.14M |
| Net Income Margin | -89.9% | -3.1% | -36.9% |
| Supplementary Data | |||
| EPS | -5.36 | -0.15 | -1.39 |
| Diluted EPS | -5.19 | -0.15 | -1.39 |
| Weighted Average OS | 79.19M | 78.02M | 78.02M |
| EBITDA | -$535.89M | -$18.48M | -$124.89M |
| EBITDA Margin | -91.2% | -4.7% | -42.7% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Assets | |||
| Current Assets | |||
| Cash and Cash Equivalents | $208M | $300.79M | $234.95M |
| Short-Term Investments | $155.87M | $165.79M | $188.4M |
| Cash and Short-Term Investments | $363.86M | $466.57M | $423.36M |
| Accounts Receivable | $66.06M | $42.49M | $46.56M |
| Inventory | $15.64M | $10.87M | $13.29M |
| Other Current Assets | $57.41M | $39.59M | $32.31M |
| Total Current Assets | $533.9M | $583.45M | $529.88M |
| Long-Term Assets | |||
| Property, Plant & Equipment Net | $17.35M | $16.99M | $22.48M |
| Goodwill | $64.1M | $61.61M | $61.61M |
| Intangible Assets | $2.51M | $1.81M | $2.19M |
| Long-Term Investments | $113.17M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 |
| Other Long-Term Assets | $13.73M | $9.41M | $6.38M |
| Total Long-Term Assets | $210.86M | $89.81M | $92.65M |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $744.76M | $673.26M | $622.53M |
| Liabilities | |||
| Current Liabilities | |||
| Accounts Payable | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $2.12M | $8.2M |
| Current Unearned Revenue | $300.86M | $217.63M | $140.47M |
| Other Current Liabilities | $11.46M | $4.16M | $6.37M |
| Total Current Liabilities | $362.41M | $249.3M | $184.16M |
| Long-Term Liabilities | |||
| Long-Term Debt | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 |
| Total Long-Term Liabilities | $3.82M | $7.26M | $11.1M |
| Other Liabilities | $0 | $0 | $0 |
| Total Liabilities | $366.23M | $256.56M | $195.25M |
| Stockholders' Equity | |||
| Preferred Stock | $199.87M | $851.27M | $851.27M |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$1.05B | -$522.74M | -$510.8M |
| Comprehensive Income & Other | -$20K | $68K | $60K |
| Other Stockholders' Equity | $1.43B | $939.44M | $938.08M |
| Total Equity | $378.54M | $416.7M | $427.28M |
| Minority Interest | $0 | $0 | $0 |
| Total Liabilities and Equity | $744.76M | $673.26M | $622.53M |
| Supplementary Data | |||
| Total Debt | $8.04M | $11.07M | $15.73M |
| Net Debt | -$199.96M | -$289.71M | -$219.22M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Operating Activities | |||
| Net Income | -$528.26M | -$11.93M | -$108.14M |
| Depreciation & Amortization | $5.13M | $5.95M | $5.63M |
| Deferred Income Tax | $53K | -$585K | -$473K |
| Stock-Based Compensation | $643.01M | $739K | $1.65M |
| Changes in Working Capital: | |||
| Accounts Receivable | -$26.63M | -$1.34M | -$23.13M |
| Inventory | -$4.76M | $608K | $10.56M |
| Accounts Payable | $29.41M | -$10.97M | $0 |
| Other Working Capital | -$31K | $25.21M | $21.97M |
| Total Working Capital Change | -$2.01M | $13.5M | $9.41M |
| Other Non-Cash Items | $53.52M | $41.33M | $28.02M |
| Net Cash from Operating | $171.44M | $49M | -$63.91M |
| Investing Activities | |||
| Capital Expenditures | -$708K | -$1.04M | -$1.98M |
| Acquisitions | -$4M | $0 | $0 |
| Purchases of Investments | -$472.29M | -$324.54M | -$453.33M |
| Sales of Investments | $368.59M | $346.63M | $459.45M |
| Other Investing Activities | -$5.36M | -$2.73M | -$2.64M |
| Net Cash from Investing | -$113.76M | $18.31M | $1.5M |
| Financing Activities | |||
| Debt Repaid | - | - | - |
| Common Stock Issuance | $265.2M | $610K | $0 |
| Common Stock Repurchases | -$65.03M | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing Activities | -$350.64M | -$2.81M | -$3M |
| Net Cash from Financing | -$150.47M | -$2.2M | -$3M |
| Forex Effect | $0 | $0 | $0 |
| Net Change in Cash | -$92.79M | $65.11M | -$65.41M |
| Supplementary Data | |||
| Operating Cash Flow | $171.44M | $49M | -$63.91M |
| Capital Expenditure | -$708K | -$3.77M | -$4.62M |
| Free Cash Flow | $170.73M | $45.23M | -$68.52M |
| Cash at Beginning | $302.59M | $237.47M | $302.88M |
| Cash at End | $209.8M | $302.59M | $237.47M |